Shih IM - Search Results

1

Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1.

Jung JG, Shih IM, Park JT, Gerry E, Kim TH, Ayhan A, Handschuh K, Davidson B, Fader AN, Selleri L, Wang TL. Jung JG, et al. Among authors: shih im. Cancer Res. 2016 Nov 1;76(21):6351-6361. doi: 10.1158/0008-5472.CAN-16-0980. Epub 2016 Sep 2. Cancer Res. 2016. PMID: 27590741 Free PMC article.

2

Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells.

Shih I, Wang T, Wu T, Kurman RJ, Gearhart JD. Shih I, et al. J Cell Sci. 1998 Sep;111 ( Pt 17):2655-64. doi: 10.1242/jcs.111.17.2655. J Cell Sci. 1998. PMID: 9701564

3

Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms.

Shih IM, Wang TL, Westra WH. Shih IM, et al. Clin Cancer Res. 1996 Mar;2(3):569-75. Clin Cancer Res. 1996. PMID: 9816205

4

The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.

Shih IM, Yu J, He TC, Vogelstein B, Kinzler KW. Shih IM, et al. Cancer Res. 2000 Mar 15;60(6):1671-6. Cancer Res. 2000. PMID: 10749138

5

Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity.

Wang TL, Ling M, Shih IM, Pham T, Pai SI, Lu Z, Kurman RJ, Pardoll DM, Wu TC. Wang TL, et al. Among authors: shih im. Gene Ther. 2000 May;7(9):726-33. doi: 10.1038/sj.gt.3301160. Gene Ther. 2000. PMID: 10822298

6

Top-down morphogenesis of colorectal tumors.

Shih IM, Wang TL, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, Kinzler KW, Vogelstein B. Shih IM, et al. Proc Natl Acad Sci U S A. 2001 Feb 27;98(5):2640-5. doi: 10.1073/pnas.051629398. Epub 2001 Feb 20. Proc Natl Acad Sci U S A. 2001. PMID: 11226292 Free PMC article.

7

Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis.

Chang HW, Ali SZ, Cho SK, Kurman RJ, Shih IeM. Chang HW, et al. Clin Cancer Res. 2002 Aug;8(8):2580-5. Clin Cancer Res. 2002. PMID: 12171887

8

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma.

Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih IeM. Singer G, et al. J Natl Cancer Inst. 2003 Mar 19;95(6):484-6. doi: 10.1093/jnci/95.6.484. J Natl Cancer Inst. 2003. PMID: 12644542

9

Increased plasma DNA integrity in cancer patients.

Wang BG, Huang HY, Chen YC, Bristow RE, Kassauei K, Cheng CC, Roden R, Sokoll LJ, Chan DW, Shih IeM. Wang BG, et al. Cancer Res. 2003 Jul 15;63(14):3966-8. Cancer Res. 2003. PMID: 12873992

10

Identifying tumor origin using a gene expression-based classification map.

Buckhaults P, Zhang Z, Chen YC, Wang TL, St Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, Velculescu VE, Shih IeM. Buckhaults P, et al. Cancer Res. 2003 Jul 15;63(14):4144-9. Cancer Res. 2003. PMID: 12874019

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

387 results

Search Page